Market regulators are looking into whether biotech developer Blis Technologies [NZX:BLT] breached continuous disclosure regulations after a weekend newspaper published potentially market sensitive information before it appeared on the NZX.
Under NZX listing rules and the Securities Markets
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Calida Smylie
Wed, 27 Aug 2014
Wed, 27 Aug 2014
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Regulators investigating possible Blis trading breach
40813